Dr. Reddy's: Buy Rating Boosts Stock

  Published 1 year ago

Dr. Reddy's Laboratories stock is rising following a 'Buy' recommendation from Motilal Oswal. Their Conviction Delivery Idea sets a ₹1,316 target price, with a ₹1,215 stop loss, signaling positive investor sentiment.

  • Motilal Oswal initiates a 'Buy' call.
  • Target price set at ₹1,316.
  • Stop loss advised at ₹1,215.

You might like these

Mphasis & Sixfold AI Boost Insurance Efficiency

Nilkamal Shares Slide 5% on Profit Drop

India's Economic Growth: OECD Forecast

Anush Raghavan Promoted to CMS Chief Business Officer

Waaree Wins ₹346 Crore Solar Project

Denosumab Biosimilars Approved in Europe

LT Foods Expands Organic Biz in Europe

News that matters the most ⚡